Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May:155:104741.
doi: 10.1016/j.phrs.2020.104741. Epub 2020 Mar 6.

Mechanistic insights of adipocyte metabolism in regulating breast cancer progression

Affiliations
Free article
Review

Mechanistic insights of adipocyte metabolism in regulating breast cancer progression

Fuchuang Zhang et al. Pharmacol Res. 2020 May.
Free article

Abstract

Adipocyte account for the largest component in breast tissue. Dysfunctional adipocyte metabolism, such as metaflammation in metabolically abnormal obese patients, will cause hyperplasia and hypertrophy of its constituent adipocytes. Inflamed adipose tissue is one of the biggest risk factors causing breast cancer. Factors linking adipocyte metabolism to breast cancer include dysfunctional secretion of proinflammatory mediators, proangiogenic factors and estrogens. The accumulation of tumor supporting cells and systemic effects, such as insulin resistance, dyslipidemia and oxidative stress, which are caused by abnormal adipocyte metabolism, further contribute to a more aggressive tumor microenvironment and stimulate breast cancer stem cell to influence the development and progression of breast cancer. Here, in this review, we focus on the adipocyte metabolism in regulating breast cancer progression, and discuss the potential targets which can be used for breast cancer therapy.

Keywords: Adipocyte; Breast cancer; Breast cancer therapy.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest All authors have read the manuscript and approved its submission for publication. None of the authors have conflicts of interest to declare.

Publication types